Long-term outcome following successful pulmonary vein isolation: Pattern and prediction of very late recurrence

Journal of Cardiovascular Electrophysiology

Volumn 19, Issue 7, 2008, Pages 661-667

  Shah, Arti N ^a   Mittal, Suneet ^a   Sichrovsky, Tina C ^a   Cotiga, Delia ^a   Arshad, Aysha ^a   Maleki, Kataneh ^a   Pierce, Walter J ^a   Steinberg, Jonathan S ^a,b  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

Atrial fibrillation; Catheter ablation; Hyperlipidemia; Hypertension; Pulmonary vein isolation; Recurrence

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; DOFETILIDE; FLECAINIDE; PROPAFENONE; SOTALOL;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CATHETER ABLATION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PULMONARY VEIN; PULMONARY VEIN ABLATION; RECURRENCE RISK; REPEAT PROCEDURE;

ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEW YORK; PREVALENCE; PROGNOSIS; PULMONARY VEINS; RECURRENCE; TREATMENT OUTCOME;

EID: 47949129025     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2008.01101.x     Document Type: Article

References (28)

1. Haïssaguerre M, Marcus FI, Fischer B, Clémenty J : Radiofrequency catheter ablation in unusual mechanisms of atrial fibrillation: Report on three cases. J Cardiovasc Electrophysiol 1994 5 : 743 751.
2. Haïssaguerre M, Jaïs P, Shah DC, Gencel L, Pradeau V, Garrigues S, Chouairi S, Hocini M, Le Métayer P, Roudaut R, Clémenty J : Right and left atrial radiofrequency catheter therapy of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 1996 7 : 1132 1144.
3. Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P, Clémenty J : Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998 339 : 659 666.
4. Gerstenfeld EP, Callans DJ, Dixit S, Zado E, Marchlinski FE : Incidence and location of focal atrial fibrillation triggers in patients undergoing repeat pulmonary vein isolation: Implications for ablation strategies. J Cardiovasc Electrophysiol 2003 14 : 685 690.
5. Chen SA, Hsieh MH, Tai CT, Tsai CF, Prakash VS, Yu WC, Hsu TL, Ding YA, Chang MS : Initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins: Electrophysiologic characteristics, pharmacologic responses, and effects of radiofrequency ablation. Circulation 1999 100 : 1879 1886.
6. Shah DC, Haïssaguerre M, Jaïs P, Hocini M, Yamane T, Deisenhofer I, Garrigue S, Clémenty J : Electrophysiologically guided ablation of the pulmonary veins for the curative treatment of atrial fibrillation. Ann Med 2000 32 : 408 416.
7. Gerstenfeld EP, Guerra P, Sparks PB, Hattori K, Lesh MD : Clinical outcome after radiofrequency catheter ablation of focal atrial fibrillation triggers. J Cardiovasc Electrophysiol 2001 12 : 900 908.
8. Hsieh MH, Tai CT, Lee SH, Lin YK, Tsao HM, Chang SL, Lin YJ, Wongchaoen W, Lee KT, Chen SA : The different mechanisms between late and very late recurrences of atrial fibrillation in patients undergoing a repeated catheter ablation. J Cardiovasc Electrophysiol 2006 17 : 231 235.
9. Herweg B, Sichrovsky T, Polosajian L, Vloka M, Rozenshtein A, Steinberg JS : Anatomic substrate, procedural results, and clinical outcome of ultrasound-guided left atrial-pulmonary vein disconnection for treatment of atrial fibrillation. Am J Cardiol 2005 95 : 871 875.
10. Ernst S, Schlüter M, Ouyang F, Khanedani A, Cappato R, Hebe J, Volkmer M, Antz M, Kuck KH : Modification of the substrate for maintenance of idiopathic human atrial fibrillation: Efficacy of radiofrequency ablation using nonfluoroscopic catheter guidance. Circulation 1999 100 : 2085 2092.
11. Pappone C, Oreto G, Lamberti F, Vicedomini G, Loricchio ML, Shpun M, Rillo M, Calabro MP, Conversano A, Ben-Haim SA, Cappato R, Chierchia S : Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system. Circulation 1999 100 : 1203 1208.
12. Hsieh MH, Tai CT, Tsai CF, Lin WS, Lin YK, Tsao HM, Huang JL, Ueng KC, Yu WC, Chan P, Ding YA, Chang MS, Chen SA : Clinical outcome of very late recurrence of atrial fibrillation after catheter ablation of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 2003 14 : 598 601.
13. Lee SH, Tai CT, Hsieh MH, Tsai CF, Lin YK, Tsao HM, Yu WC, Huang JL, Ueng KC, Cheng JJ, Ding YA, Chen SA : Predictors of early and late recurrence of atrial fibrillation after catheter ablation of paroxysmal atrial fibrillation. J Interv Card Electrophysiol 2004 10 : 221 226.
14. Mainigi SK, Sauer WH, Cooper JM, Dixit S, Gerstenfeld EP, Callans DJ, Russo AM, Verdino RJ, Lin D, Zado ES, Marchlinski FE : Incidence and predictors of very late recurrence of atrial fibrillation after ablation. J Cardiovasc Electrophysiol 2007 18 : 69 74.
15. Oral H, Chugh A, Ozaydin M, Good E, Fortino J, Sankaran S, Reich S, Igic P, Elmouchi D, Tschopp D, Wimmer A, Dey S, Crawford T, Pelosi F, Jongnarangsin K, Bogun F : Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation 2006 114 : 759 765.
16. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL American College of Cardiology/American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) : Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006 114 : e257 354 and J Am Coll Cardiol 2006;48:854-906.
17. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, Damiano RJ Jr., Davies DW, Haines DE, Haïssaguerre M, Iesaka Y, Jackman W, Jaïs P, Kottkamp H, Kuck KH, Lindsay BD, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Natale A, Pappone C, Prystowsky E, Raviele A, Ruskin JN, Shemin RJ Heart Rhythm Society; European Heart Rhythm Association; European Cardiac Arrhythmia Society; American College of Cardiology; American Heart Association; Society of Thoracic Surgeons. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS) : Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace 2007 9 : 335 379.
18. Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfinkle M, Yusuf S, Connolly SJ : Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: A meta-analysis. J Am Coll Cardiol 2005 45 : 1832 1839.
19. Hirayama Y, Atarashi H, Kobayashi Y, Horie T, Iwasaki Y, Maruyama M, Miyauchi Y, Ohara T, Yashima M, Takano T : Angiotensin-converting enzyme inhibitor therapy inhibits the progression from paroxysmal atrial fibrillation to chronic atrial fibrillation. Circ J 2005 69 : 671 676.
20. Al-Khatib SM : Angiotensin-converting enzyme inhibitors: A new therapy for atrial fibrillation? Am Heart J 2004 147 : 751 752.
21. Hanna IR, Heeke B, Bush H, Brosius L, King-Hageman D, Dudley SC Jr., Beshai JF, Langberg JJ : Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction. Heart Rhythm 2006 3 : 881 886.
22. Kantharia BK : Lipid-lowering drugs: Beyond lowering lipid levels to their influence on cardiac arrhythmias. Heart Rhythm 2006 3 : 887 888.
23. Al Chekakie MO, Akar JG, Wang F, Al Muradi H, Wu J, Santucci P, Varma N, Wilber DJ : The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation. J Cardiovasc Electrophysiol 2007 18 : 942 946.
24. Lally JA, Gnall EM, Seltzer J, Kowey PR : Non-antiarrhythmic drugs in atrial fibrillation; a review of nonpantiarrhythmic agents in prevention of atrial fibrillation. J Cardiovasc Electrophysiol 2007 18 : 1222 1228.
25. Joshi S, Bangalore S, Chiadika S, Steinberg JS : Defining the "blanking period" after ablation of atrial fibrillation: Systematic study using a continuous autotrigger recorder for 3 months. Circulation 2006 II-606 : 2893.
26. Ford ES, Mokdad AH, Giles WH, Mensah GA : Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: Findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation 2003 107 : 2185 2189.
27. Arnett DK, Jacobs DR, Luepker RV, Blackburn H, Armstrong C, Claas SA : Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: The Minnesota Heart Survey, 1980-1982 to 2000-2002. Circulation 2005 112 : 3884 3891.
28. Wong ND, Lopez V, Tang S, Williams GR : Prevalence, treatment, and control of combined hypertension and hypercholesterolemia in the United States. Am J Cardiol 2006 98 : 204 208.